Consolidative radiation therapy may provide a significant benefit to patients with specific subtypes of diffuse large B-cell lymphoma. READ MORE
Research in Review
Maintenance therapy with a targeting agent may provide survival benefits beyond first- and second-line chemotherapy in patients with diffuse large B-cell lymphoma, according to an analysis published in PLOS One.
Patients with mantle cell lymphoma benefit from prolonged event-free survival and overall survival when treated with autologous stem cell transplantation and total body irradiation.
Establishment of Subspecialized Care in Hematologic Malignancies and a Hematopoietic Cell Transplant Program
The Levine Cancer Institute of the Carolinas HealthCare System has had a large impact on hematopoietic cell transplant outcomes.
Two new studies suggest a role for blood tests, or liquid biopsies, in guiding a patient’s cancer treatment.